Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2017, Article ID 8472930, 3 pages
https://doi.org/10.1155/2017/8472930
Case Report

Successful Treatment of Clostridium difficile Bacteremia with Aortic Mycotic Aneurysm in a Patient with Prior Endovascular Aortic Aneurysm Repair

Division of Infectious Diseases and Global Medicine, Department of Medicine, University of Florida, College of Medicine, 1600 SW Archer Rd., Gainesville, FL 32610, USA

Correspondence should be addressed to Kairav Shah; moc.liamg@hahsvariak

Received 18 January 2017; Revised 6 February 2017; Accepted 8 February 2017; Published 27 February 2017

Academic Editor: Alexandre Rodrigues Marra

Copyright © 2017 Kairav Shah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Mattila, P. Arkkila, P. S. Mattila, E. Tarkka, P. Tissari, and V.-J. Anttila, “Extraintestinal clostridium difficile infections,” Clinical Infectious Diseases, vol. 57, no. 6, pp. e148–e153, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. D. B. Libby and G. Bearman, “Bacteremia due to Clostridium difficile—review of the literature,” International Journal of Infectious Diseases, vol. 13, no. 5, pp. e305–e309, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. Table 2J-1, Minimal Inhibitory Concentration Breakpoints for Anaerobes; CLSI. Performance Standards for Antimicrobial Susceptibility Testing, CLSI Document M100-S27, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 27th edition, 2016.
  4. C. W. Seder, M. Kramer, G. Long, M. R. Uzieblo, C. J. Shanley, and P. Bove, “Clostridium septicum aortitis: report of two cases and review of the literature,” Journal of Vascular Surgery, vol. 49, no. 5, pp. 1304–1309, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. D. Forrester, E. Shkolyar, D. Gregg, D. A. Spain, and T. G. Weiser, “Nontraumatic clostridium septicum myonecrosis in adults: case report and a 15-year systematic literature review,” Infectious Diseases in Clinical Practice, vol. 24, no. 6, pp. 318–323, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. C. L. Kennedy, E. O. Krejany, L. F. Young et al., “The α-toxin of Clostridium septicum is essential for virulence,” Molecular Microbiology, vol. 57, no. 5, pp. 1357–1366, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. N.-Y. Lee, Y.-T. Huang, P.-R. Hsueh, and W.-C. Ko, “Clostridium difficile bacteremia, Taiwan,” Emerging Infectious Diseases, vol. 16, no. 8, pp. 1204–1210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J.-L. Choi, B.-R. Kim, J.-E. Kim et al., “A case of Clostridium difficile bacteremia in a patient with loop ileostomy,” Annals of Laboratory Medicine, vol. 33, no. 3, pp. 200–202, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Tsukioka, K. Takahashi, T. Gomibuchi, T. Kono, T. Yajima, and M. Owa, “Mycotic iliac artery aneurysm caused by Clostridiumdifficilein a patient with axillobifemoral bypass for leriche syndrome,” Annals of Vascular Diseases, vol. 6, no. 1, pp. 87–90, 2013. View at Publisher · View at Google Scholar
  10. F. Dick, N. Diehm, M. Gerber et al., “Aortitis following percutaneous aortic side branch embolization prior to endovascular repair of infrarenal aortic aneurysm,” Journal of Endovascular Therapy, vol. 14, no. 6, pp. 801–804, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Sathyendran, T. V. Riley, S. A. Roberts, and J. T. Freeman, “Mycotic abdominal aortic aneurysm caused by toxigenic Clostridium difficile,” Anaerobe, vol. 18, no. 3, pp. 270–272, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Freeman, J. Vernon, K. Morris et al., “Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes,” Clinical Microbiology and Infection, vol. 21, no. 3, pp. 248.e9–248.e16, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Baines and M. Wilcox, “Antimicrobial resistance and reduced susceptibility in clostridium difficile: potential consequences for induction, treatment, and recurrence of C. difficile infection,” Antibiotics, vol. 4, no. 3, pp. 267–298, 2015. View at Publisher · View at Google Scholar
  14. J. Purdell, W. Fawley, J. Freeman, and M. H. Wilcox, “Investigation of outcome in cases of Clostridium difficile infection due to isolates with reduced susceptibility to metronidazole,” in Proceedings of the 21st European Congress of Clinical Microbiology and Infectious Diseases, Milan, Italy, May 2011.
  15. C. Daruwala, G. Mercogliano, G. Newman, and M. J. Ingerman, “Bacteremia due to clostridium difficile: case report and review of the literature,” Clinical Medicine: Case Reports, vol. 2009, no. 2, pp. 5–9, 2009. View at Google Scholar · View at Scopus